RegionsNorth AmericaEuropeIsraelIndiaSoutheast AsiaEast AsiaLatin AmericaMiddle EastAfricaOceaniaGlobalUpdated 20 October 2026
AcquiredStartups
SearchExit tracker
Biggest in 8VC
Roche → PathAI$1.05bnAcquisition
Investor

8VC

2Exits tracked$1.05bnDisclosed value$1.05bnMedian price0Acquihires

Startups backed by 8VC that were acquired: 2 exits so far, with the buyer, the price where disclosed and every source.

Image: Orchestra Bio
AI · San Francisco

OpenAI acquires Orchestra Bio to add drug-development agents to its Rosalind unit

Orchestra Bio's AI agents track the studies, budgets and timelines behind a drug programme and flag problems such as a failed manufacturing batch that threatens a clinical trial.

PriceUndisclosedRaised$20mLast stageStage n/aBuyer typeBig Tech
Latest in 8VCBoston · Healthtech & bioRoche agrees to buy digital pathology company PathAI for up to $1.05 billion$1bn+Series C7 May
All 8VC exitsOpen tracker →
20 OctOpenAI → Orchestra BioSan Francisco · Stage n/a · raised $20mUndisclosedUndisclosed7 MayRoche → PathAIBoston · Series C · raised n/a$1.05bn$1bn+